======= ACAT2 =======
== Gene Information ==
* **Official Symbol**: ACAT2
* **Official Name**: acetyl-CoA acetyltransferase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=39|39]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BWD1|Q9BWD1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ACAT2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACAT2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/100678|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The product of this gene is an enzyme involved in lipid metabolism, and it encodes cytosolic acetoacetyl-CoA thiolase. This gene shows complementary overlapping with the 3-prime region of the TCP1 gene in both mouse and human. These genes are encoded on opposite strands of DNA, as well as in opposite transcriptional orientation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2014].
* **UniProt Summary**: N/A
|Thiolase N|
|Thiolase C|
|acetyl-CoA C-acetyltransferase activity|
|acetyl-CoA C-acyltransferase activity|
|cholesterol biosynthetic process|
|secondary alcohol biosynthetic process|
|sterol biosynthetic process|
|fatty acid beta-oxidation|
|fatty acid oxidation|
|lipid oxidation|
|fatty acid catabolic process|
|alcohol biosynthetic process|
|cholesterol metabolic process|
|monocarboxylic acid catabolic process|
|steroid biosynthetic process|
|secondary alcohol metabolic process|
|sterol metabolic process|
|organic hydroxy compound biosynthetic process|
|cellular lipid catabolic process|
|lipid modification|
|steroid metabolic process|
|carboxylic acid catabolic process|
|organic acid catabolic process|
|lipid catabolic process|
|alcohol metabolic process|
|fatty acid metabolic process|
|small molecule catabolic process|
|organic hydroxy compound metabolic process|
|monocarboxylic acid metabolic process|
|lipid biosynthetic process|
|small molecule biosynthetic process|
|nucleolus|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|lipid metabolic process|
|mitochondrion|
|organic cyclic compound biosynthetic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-3.76|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-3.55|
|[[:results:exp452|Azithromycin 100μM R08 exp452]]|-2.89|
|[[:results:exp151|SGC0946 7μM R03 exp151]]|-2.29|
|[[:results:exp155|UNC1999 2μM R03 exp155]]|-2.21|
|[[:results:exp124|GSK343 3μM R03 exp124]]|-1.82|
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.19|
^Gene^Correlation^
|[[:human genes:s:srebf2|SREBF2]]|0.408|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18468
* **Expression level (log2 read counts)**: 6.15
{{:chemogenomics:nalm6 dist.png?nolink |}}